GT Biopharma, Inc. (GTBP) NASDAQ
0.28
+0.003(+1.07%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.28
+0.003(+1.07%)
Currency In USD
| Market Cap | 4.33M |
| Enterprise Value | -2.48M |
| P/E Ratio | -0.06 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3.5 |
| Return On Equity | -8.98 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -34.32M |
| Net Income | -28.35M |
| Diluted EPS | -6.25 |
| Total Cash | 6.81M |
| Total Cash/Share | 1.24 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.5 |
| Book Value Per Share | 1.05 |
| 52-Week Change | -87.7 |
| 52-Week High | 3.85 |
| 52-Week Low | 0.27 |
| Moving Average 50 Days | 0.42 |
| Moving Average 200 Days | 0.82 |
| Average Volume | 909,809 |
| Shares Outstanding | 10.62M |
| % Held by Institutions | 12.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:30 |
| Last Split Date | February 05, 2024 |